June 17, 2015
- Efficacy of dual-hormone artificial pancreas to alleviate the carbohydrate-counting burden of type 1 diabetes: A randomized crossover trial.
- Outpatient overnight glucose control with dual-hormone artificial pancreas, single-hormone artificial pancreas, or conventional insulin pump therapy in children and adolescents with type 1 diabetes: an open-label, randomised controlled trial. See also Which artificial pancreas system is the best for children with type 1 diabetes?
- Artificial Pancreas (AP) Technology Take the Stage at the 75th Annual American Diabetes Association (ADA) Conference.
- Hope Ahead? Varying Approaches Progress Artificial Pancreas.
- Bionic pancreas effective therapy in preadolescent summer camp setting.
- Non-HLA gene effects on the disease process of type 1 diabetes: From HLA susceptibility to overt disease.
- Alpha-1 antitrypsin therapy is safe and well tolerated in children and adolescents with recent onset type 1 diabetes mellitus.
- Common Sequence Variation in the VEGFC Gene Is Associated with Diabetic Retinopathy and Diabetic Macular Edema.
- Family history and ethnicity influencing clinical presentation of type 1 diabetes in childhood.
- Parents’ experiences 12 years after newborn screening for genetic susceptibility to type 1 diabetes and their attitudes to whole-genome sequencing in newborns.
- Extreme Beta-Cell Deficiency in Pancreata of Dogs with Canine Diabetes. Free full text available in HTML and PDF formats.
